The molecular docking and MD simulation investigations were carried out against phytochemicals with anti-diabetic and anti-obesity properties to shortlist the best SFRP4 inhibitor. This evidence concerns the gene SFRP4 and obesity due to melanocortin 4 receptor deficiency.